Average Co-Inventor Count = 7.61
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (43 from 1,151 patents)
2. Merck Patent Gmbh (3 from 2,943 patents)
3. Cellarity, Inc. (2 from 3 patents)
45 patents:
1. 12502376 - Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)
2. 12473285 - DCN-1 modulating compounds and methods of use thereof
3. 12435087 - Modulators of DCN-1 and methods of use thereof
4. 12331057 - Modulators of alpha-1 antitrypsin
5. 12251387 - Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
6. 12195453 - Antiproliferation compounds and uses thereof
7. 12005127 - DNA-PK inhibitors
8. 11884672 - Modulators of alpha-1 antitrypsin
9. 11813267 - DNA-PK inhibitors
10. RE49500 - Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
11. 11623924 - Modulators of alpha-1 antitrypsin
12. 11440907 - Antiproliferation compounds and uses thereof
13. 10973830 - Substituted quinoxaline DNA-PK inhibitors
14. 10815225 - Antiproliferation compounds and uses thereof
15. RE48266 - Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto